Frequently Asked Questions

Preclinical Research

A common concern among startups and device developers is the length of time it will take to start testing.  Teams may expedite schedules, produce early safety and performance data, and get closer to regulatory submissions without needless delays at IBEX because studies can begin as soon as two to three weeks following initial contact.

GLP compliance guarantees that the data gathered satisfies firm documentation and quality requirements accepted by the FDA and other international regulatory agencies.  This gives MedTech inventors assurance that their preclinical results will withstand regulatory assessment because the study is reliable, repeatable, and audit-ready.

Orthopedic implants, spinal fixation systems, corrective tools, drain, imaging-guided devices, surgical sealants, and tailored biotech solutions are just a few of the many products that IBEX supports.  Device teams at MedTech companies, whether they are new or well-established, depend on IBEX to provide clinically relevant models that accurately represent real-world use.

Yes. IBEX provides live large-animal models for physician training in a cadaver-free, realistic setting. In the same location as preclinical testing, surgeons can test placement, assess usability, and give feedback as device teams perfect performance in real time.

IBEX’s process is centered on ethics and responsible research. The team applies the 3Rs principle by:

  • Replacing animal use when alternative methods are valid.
  • Lowering the animal population by the use of data-rich models and sophisticated imagery.
  • Enhancing procedures to reduce suffering and improve animal welfare.

This strategy strikes a balance between compassionate research methods that meet international standards and creativity.

Orthopedic Preclinical Research

IBEX uses state-of-the-art imaging technologies, such as X-ray, CT, and MRI, and meticulously replicates clinical situations to provide precise, scalable, and meeting requirements results for orthopedic devices. For all procedures, IBEX uses veterinarians with preclinical research expertise.

IBEX evaluates biomaterials, joint replacements, implants, and other musculoskeletal procedures.

From preliminary feasibility testing to follow-ups after approval, IBEX offers comprehensive regulatory positing help.

Preclinical Research Facility & Equipment Services

Orthopedics, dentistry, neurology, cardiology, ophthalmology, wound care, gastrointestinal, and toxicology are just a few of the therapeutic areas in which IBEX provides vast preclinical research capabilities, including in-vivo medical device implantation and safety studies. Their state-of-the-art vivarium, surgical suite, and imaging systems enable accurate, notable research.

To guarantee accuracy, IBEX employs a range of animals, such as rats, rabbits, lambs, and dogs, simulation of clinical conditions.

The faculty does adhere to FDA, USDA, and OLAW direction for ethical research and animal care, and they are AAALAC-accredited.

The IBEX facility has a 500-square-foot operating room, a 10-room vivarium with an outside barn, and original imaging equipment like CT, digital X-ray, MRI, fluoroscopy, and ultrasound. Observer can carry out multiple surgeries at once with this configuration, track in vivo development in real time, and produce high-quality data for device and treatment pricing.

Soft Tissue Surgery Preclinical Research

Because it assesses the recital, safety, and effectiveness of surgical instruments and methods prior to human usage, preclinical soft tissue surgery research is essential.  It improves clinical results and patient safety by assisting in the identification of possible dangers including rawness, infection, or tissue responses, honing surgical techniques, and supplying reliable data to back up regulatory applications.

A variety of procedures are tested by IBEX, such as organ repair, wound healing, circulatory grafts, and catheter implantations.

Every study complies with GLP and is intended to produce data appropriate for submission to the FDA and other regulatory bodies.